Most AI medical devices cleared for use were not tested on patient outcomes - EurekAlert!
Reported by EurekAlert! · all stories from eurekalert.org
Editorial digest
A concerning finding reveals that most artificial intelligence medical devices granted regulatory clearance did not undergo testing specifically focused on patient outcomes.
Digests are written in our own words from the publisher's headline — we never reproduce article text. Read the original for the full reporting.
Read the full story at EurekAlert! →More like this
Other stories our editors tagged with the same themes.
- Reputable trade press8/19/2026
Most AI medical devices cleared for use were not tested on patient outcomes - Medical Xpress
Most cleared AI medical devices lacked patient outcome testing.
- Reputable trade press8/19/2026
Nearly All FDA-Cleared AI Medical Devices Lack Evidence of Patient Benefit - Inside Precision Medicine
Most FDA-approved AI medical devices lack strong evidence of direct patient benefit.
- Reputable trade press8/20/2026
FDA-cleared medical AI rarely tested for real-world benefits - News-Medical
FDA-cleared medical AI often lacks real-world benefit testing.
- Trusted health newsroom9/9/2026
STAT+: ARPA-H to invest $62 million to develop FDA-authorized AI to help treat heart failure
ARPA-H plans to invest $62 million in FDA-authorized AI for heart failure treatment.
- Official source7/23/2026
Digital Health Technologies (DHTs) for Drug Development - fda.gov
The FDA issued guidance on Digital Health Technologies for drug development.
- Trusted health newsroom9/3/2026
STAT+: FDA pilot offers generative AI medical devices a path to patients before they are authorized
FDA pilot program allows generative AI devices to reach patients pre-authorization.